Advertisement

Reactions Weekly

, Volume 1746, Issue 1, pp 5–5 | Cite as

Xylometazoline linked with risk of serious arrhythmias?

News item
  • 29 Downloads

Reference

  1. National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Xylometazoline: Increased Risk of Serious Ventricular Arrhythmia in Patients with Long QT Syndrome. Internet Document : 15 Mar 2019. Available from: URL: https://www.npra.gov.my/index.php/en/component/content/article/414-english/safety-alerts-main/safety-alerts-2019/

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations